roflumilast 250 MCG Oral Tablet

RxCUI
2001319
RxNorm name
roflumilast 250 MCG Oral Tablet
Display name
roflumilast 250 MCG Oral Tablet
Full name
roflumilast 250 MCG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:21

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 12 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RoflumilastROFLUMILASTJubilant Cadista Pharmaceuticals Inc.aaa81c1b-f63d-4e61-8bfa-9d42d92043c72026-07-14Warnings, Adverse reactionsExact identifier
rxcui: 2001319
roflumilastROFLUMILASTAvKARE55009549-3f0c-1f58-e063-6294a90a6c032026-06-24Warnings, Adverse reactionsExact identifier
rxcui: 2001319
ROFLUMILASTROFLUMILASTAmici Pharma Inc.cb3781ff-5350-4f9a-b247-0b04eb0f2b922026-05-19Warnings, Adverse reactionsExact identifier
rxcui: 2001319
RoflumilastROFLUMILASTMAJOR PHARMACEUTICALSc51b80f3-a591-4db9-81b4-b91603e35d7c2025-12-04Warnings, Adverse reactionsExact identifier
rxcui: 2001319
ROFLUMILASTROFLUMILASTMicro Labs Limiteddc2a689f-cfa4-4863-9623-a9813dcf86a92025-07-24Warnings, Adverse reactionsExact identifier
rxcui: 2001319
ROFLUMILASTROFLUMILASTAurobindo Pharma Limited7cb11d48-6bb9-437b-bc7f-382050a2d3e62025-05-27Warnings, Adverse reactionsExact identifier
rxcui: 2001319
RoflumilastROFLUMILASTAscend Laboratories, LLC93d72a99-64dc-4fde-a5b8-78331fa607872025-03-13Warnings, Adverse reactionsExact identifier
rxcui: 2001319
RoflumilastROFLUMILASTNovadoz Pharmaceuticals LLC4d25f69c-58b7-4e2a-b835-4d0c76a83c7c2024-08-27Warnings, Adverse reactionsExact identifier
rxcui: 2001319
RoflumilastROFLUMILASTZydus Pharmaceuticals USA Inc.84145572-f320-4c3f-ab29-bd9f6c18746c2024-08-16Warnings, Adverse reactionsExact identifier
rxcui: 2001319
RoflumilastROFLUMILASTZydus Lifesciences Limitede87287bd-eae3-46c3-9072-04800aeabf402024-08-12Exact identifier
rxcui: 2001319
RoflumilastROFLUMILASTCamber Pharmaceuticals, Inc.f25a0230-3cf6-4366-bebe-0ea5ff8de5ab2023-04-28Warnings, Adverse reactionsExact identifier
rxcui: 2001319
DalirespROFLUMILASTAstraZeneca Pharmaceuticals LPc9a1d0a8-581f-4f91-a2b8-f419192d0ebf2020-03-12Warnings, Adverse reactionsExact identifier
rxcui: 2001319

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 12 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
c9a1d0a8-581f-4f91-a2b8-f419192d0ebfroflumilast 250 MCG Oral Tablet [PSN] · roflumilast 0.25 MG Oral Tablet [SCD] · roflumilast 250 MCG Oral Tablet [SY]315These highlights do not include all the information needed to use DALIRESP safely and effectively. See full prescribing information for DALIRESP. DALIRESP ® (roflumilast) tablets Initial U.S. Approval: 201120200312
78d2644d-b62c-48f5-8407-2adf09bcb144roflumilast 250 MCG Oral Tablet [PSN] · roflumilast 0.25 MG Oral Tablet [SCD] · roflumilast 250 MCG Oral Tablet [SY]38These highlights do not include all the information needed to use ROFLUMILAST tablets safely and effectively. See full prescribing information for ROFLUMILAST tablets. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 201120260109
dc2a689f-cfa4-4863-9623-a9813dcf86a9roflumilast 250 MCG Oral Tablet [PSN] · roflumilast 0.25 MG Oral Tablet [SCD] · roflumilast 250 MCG Oral Tablet [SY]36These highlights do not include all the information needed to use ROFLUMILAST TABLETS safely and effectively. See full prescribing information for ROFLUMILAST TABLETS. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 201120250724
7cb11d48-6bb9-437b-bc7f-382050a2d3e6roflumilast 250 MCG Oral Tablet [PSN] · roflumilast 0.25 MG Oral Tablet [SCD] · roflumilast 250 MCG Oral Tablet [SY]36These highlights do not include all the information needed to use ROFLUMILAST TABLETS safely and effectively. See full prescribing information for ROFLUMILAST TABLETS. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 201120250527
93d72a99-64dc-4fde-a5b8-78331fa60787roflumilast 250 MCG Oral Tablet [PSN] · roflumilast 0.25 MG Oral Tablet [SCD] · roflumilast 250 MCG Oral Tablet [SY]35These highlights do not include all the information needed to use ROFLUMILAST TABLETS safely and effectively. See full prescribing information for ROFLUMILAST TABLETS. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 201120250313
c51b80f3-a591-4db9-81b4-b91603e35d7croflumilast 250 MCG Oral Tablet [PSN] · roflumilast 0.25 MG Oral Tablet [SCD] · roflumilast 250 MCG Oral Tablet [SY]34These highlights do not include all the information needed to use ROFLUMILAST TABLETS safely and effectively. See full prescribing information for ROFLUMILAST TABLETS. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 201120251204
e87287bd-eae3-46c3-9072-04800aeabf40roflumilast 250 MCG Oral Tablet [PSN] · roflumilast 0.25 MG Oral Tablet [SCD] · roflumilast 250 MCG Oral Tablet [SY]34Roflumilast Tablets, for oral use20240812
4d25f69c-58b7-4e2a-b835-4d0c76a83c7croflumilast 250 MCG Oral Tablet [PSN] · roflumilast 0.25 MG Oral Tablet [SCD] · roflumilast 250 MCG Oral Tablet [SY]33These highlights do not include all the information needed to use ROFLUMILAST TABLETS safely and effectively. See full prescribing information for ROFLUMILAST TABLETS. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 201120240827
84145572-f320-4c3f-ab29-bd9f6c18746croflumilast 250 MCG Oral Tablet [PSN] · roflumilast 0.25 MG Oral Tablet [SCD] · roflumilast 250 MCG Oral Tablet [SY]33These highlights do not include all the information needed to use ROFLUMILAST TABLETS safely and effectively. See full prescribing information for ROFLUMILAST TABLETS. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 201120240816
cb3781ff-5350-4f9a-b247-0b04eb0f2b92roflumilast 250 MCG Oral Tablet [PSN] · roflumilast 0.25 MG Oral Tablet [SCD] · roflumilast 250 MCG Oral Tablet [SY]32These highlights do not include all the information needed to use ROFLUMILAST TABLETS safely and effectively. See full prescribing information for ROFLUMILAST TABLETS. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 201120260519
f25a0230-3cf6-4366-bebe-0ea5ff8de5abroflumilast 250 MCG Oral Tablet [PSN] · roflumilast 0.25 MG Oral Tablet [SCD] · roflumilast 250 MCG Oral Tablet [SY]32These highlights do not include all the information needed to use ROFLUMILAST TABLETS safely and effectively. See full prescribing information for ROFLUMILAST TABLETS. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 201120230428
aaa81c1b-f63d-4e61-8bfa-9d42d92043c7roflumilast 250 MCG Oral Tablet [PSN] · roflumilast 0.25 MG Oral Tablet [SCD] · roflumilast 250 MCG Oral Tablet [SY]31HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ROFLUMILAST TABLETS safely and effectively. See full prescribing information for ROFLUMILAST TABLETS. ROFLUMILAST tablets, for oral use Initial U.S. Approval: 201120260209